Identification of a Kinase Profile that Predicts Chromosome Damage Induced by Small Molecule Kinase Inhibitors

• Andrew J. Olaharski ,

  * E-mail: andrew.olaharski@roche.com

  Affiliation Non Clinical Safety, Roche Palo Alto LLC, Palo Alto, California, United States of America

  ⨯
• Nina Gonzaludo,

  Affiliation Pharma Research Scientific Informatics, Roche Palo Alto LLC, Palo Alto, California, United States of America

  ⨯
• Hans Bitter,

  Affiliation Pharma Research Scientific Informatics, Roche Palo Alto LLC, Palo Alto, California, United States of America

  ⨯
• David Goldstein,

  Affiliation Medicinal Chemistry, Roche Palo Alto LLC, Palo Alto, California, United States of America

  ⨯
• Stephan Kirchner,

  Affiliation Non Clinical Safety, F. Hoffman-La Roche AG, Basel, Switzerland

  ⨯
• Hirdesh Uppal,

  Affiliation Non Clinical Safety, Roche Palo Alto LLC, Palo Alto, California, United States of America

  ⨯
• Kyle Kolaja

  Affiliation Non Clinical Safety, Roche Palo Alto LLC, Palo Alto, California, United States of America

  ⨯